Prehospital use of dexamethasone in pulseless idioventricular rhythm

Paul M. Paris; Ronald D. Stewart; Frank Deggler

doi:10.1016/S0196-0644(84)80059-1

Prehospital use of dexamethasone in pulseless idioventricular rhythm

Paul M. Paris, Ronald D. Stewart, Frank Deggler

Research output: Contribution to journal › Article › peer-review

31 Citations (Scopus)

Abstract

We investigated the prehospital use of 100 mg dexamethasone for the treatment of cardiac arrest patients with pulseless idioventricular rhythms (PIVR). In the 86 patients studied in this prospective, randomized, double-blind investigation, four of the 46 patients receiving saline and two of the 37 patients receiving dexamethasone survived long enough to be admitted to the hospital intensive care unit. There were no long-term survivors. No benefit from the field use of 100 mg dexamethasone in PIVR could be identified in this study.

Original language	English
Pages (from-to)	1008-1010
Number of pages	3
Journal	Annals of Emergency Medicine
Volume	13
Issue number	11
DOIs	https://doi.org/10.1016/S0196-0644(84)80059-1
Publication status	Published - Nov 1984
Externally published	Yes

Bibliographical note

Funding Information:
The authors gratefully acknowledge fiscal support from Organon Pharmaceuticals and the cooperation of Director Glenn Cannon and the personnel of the City of Pittsburgh Emergency Medical Services Department.

ASJC Scopus Subject Areas

Emergency Medicine

PubMed: MeSH publication types

Clinical Trial
Journal Article

Access to Document

10.1016/S0196-0644(84)80059-1

Cite this

@article{1e8ef9a6e2074a83bfbed0e6b7c0a4d0,

title = "Prehospital use of dexamethasone in pulseless idioventricular rhythm",

abstract = "We investigated the prehospital use of 100 mg dexamethasone for the treatment of cardiac arrest patients with pulseless idioventricular rhythms (PIVR). In the 86 patients studied in this prospective, randomized, double-blind investigation, four of the 46 patients receiving saline and two of the 37 patients receiving dexamethasone survived long enough to be admitted to the hospital intensive care unit. There were no long-term survivors. No benefit from the field use of 100 mg dexamethasone in PIVR could be identified in this study.",

author = "Paris, {Paul M.} and Stewart, {Ronald D.} and Frank Deggler",

note = "Funding Information: The authors gratefully acknowledge fiscal support from Organon Pharmaceuticals and the cooperation of Director Glenn Cannon and the personnel of the City of Pittsburgh Emergency Medical Services Department.",

year = "1984",

month = nov,

doi = "10.1016/S0196-0644(84)80059-1",

language = "English",

volume = "13",

pages = "1008--1010",

journal = "Annals of Emergency Medicine",

issn = "0196-0644",

publisher = "Mosby Inc.",

number = "11",

}

TY - JOUR

T1 - Prehospital use of dexamethasone in pulseless idioventricular rhythm

AU - Paris, Paul M.

AU - Stewart, Ronald D.

AU - Deggler, Frank

N1 - Funding Information: The authors gratefully acknowledge fiscal support from Organon Pharmaceuticals and the cooperation of Director Glenn Cannon and the personnel of the City of Pittsburgh Emergency Medical Services Department.

PY - 1984/11

Y1 - 1984/11

N2 - We investigated the prehospital use of 100 mg dexamethasone for the treatment of cardiac arrest patients with pulseless idioventricular rhythms (PIVR). In the 86 patients studied in this prospective, randomized, double-blind investigation, four of the 46 patients receiving saline and two of the 37 patients receiving dexamethasone survived long enough to be admitted to the hospital intensive care unit. There were no long-term survivors. No benefit from the field use of 100 mg dexamethasone in PIVR could be identified in this study.

AB - We investigated the prehospital use of 100 mg dexamethasone for the treatment of cardiac arrest patients with pulseless idioventricular rhythms (PIVR). In the 86 patients studied in this prospective, randomized, double-blind investigation, four of the 46 patients receiving saline and two of the 37 patients receiving dexamethasone survived long enough to be admitted to the hospital intensive care unit. There were no long-term survivors. No benefit from the field use of 100 mg dexamethasone in PIVR could be identified in this study.

UR - http://www.scopus.com/inward/record.url?scp=0021733978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021733978&partnerID=8YFLogxK

U2 - 10.1016/S0196-0644(84)80059-1

DO - 10.1016/S0196-0644(84)80059-1

M3 - Article

C2 - 6385785

AN - SCOPUS:0021733978

SN - 0196-0644

VL - 13

SP - 1008

EP - 1010

JO - Annals of Emergency Medicine

JF - Annals of Emergency Medicine

IS - 11

ER -

Prehospital use of dexamethasone in pulseless idioventricular rhythm

Abstract

Bibliographical note

ASJC Scopus Subject Areas

PubMed: MeSH publication types

Access to Document

Other files and links

Fingerprint

Cite this